Earnings calendar/ABUS
Arbutus Biopharma Corp (ABUS)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 16, 2026
Consensus estimate row
EPS target
$-0.02
Street estimate
Revenue target
$1.0M
Street estimate
Trailing EPS (avg 4Q)
$0.20
Beat rate last 4: 50%
Latest EPS YoY
-400.0%
vs 2025-08-06
Latest revenue YoY
-90.6%
How results look so far
Trailing revenue (avg 4Q)
$45.6M
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 12, 2026
EPS miss
EPS actual / est
$-0.03 / $-0.02
-50.0%
Revenue actual / est
$1.0M / $700,000
+44.9%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/16/2026upcoming | $-0.02 | Pending | — | $1.0M | Pending | — |
| 8/12/2026 | $-0.02 | $-0.03 | -50.0% | $700,000 | $1.0M | +44.9% |
| 8/11/2026 | $-0.02 | $-0.03 | -50.0% | $700,000 | $1.0M | +44.9% |
| 8/10/2026upcoming | $-0.02 | Pending | — | $700,000 | Pending | — |
| 8/5/2026upcoming | $-0.02 | Pending | — | $700,000 | Pending | — |
| 5/13/2026 | $-0.03 | $0.87 | +3000.0% | $750,000 | $179.1M | +23783.5% |
| 3/26/2026upcoming | $-0.06 | Pending | — | $829,000 | Pending | — |
| 3/23/2026 | $-0.04 | $-0.01 | +71.5% | $614,500 | $1.1M | +71.0% |
| 11/13/2025 | $-0.06 | $-0.04 | +28.6% | $841,000 | $529,000 | -37.1% |
| 11/12/2025upcoming | $-0.05 | Pending | — | $1.3M | Pending | — |
| 8/6/2025 | $-0.02 | $0.01 | +150.0% | $1.6M | $10.7M | +575.0% |
| 5/14/2025 | $-0.09 | $-0.13 | -44.4% | $2.2M | $1.8M | -21.3% |
| 3/27/2025 | $-0.08 | $-0.07 | +12.5% | $2.3M | $1.6M | -30.3% |
| 11/6/2024 | $-0.10 | $-0.10 | 0.0% | $1.6M | $1.3M | -15.3% |
| 8/1/2024 | $-0.10 | $-0.11 | -10.0% | $1.9M | $1.7M | -6.7% |
| 5/2/2024 | $-0.10 | $-0.10 | 0.0% | $2.1M | $1.5M | -28.7% |
| 2/29/2024 | $-0.12 | $-0.12 | 0.0% | $4.8M | $2.1M | -55.2% |
| 11/7/2023 | $-0.12 | $-0.12 | 0.0% | $4.8M | $4.7M | -2.8% |
| 8/3/2023 | $-0.12 | $-0.10 | +16.7% | $6.2M | $4.7M | -24.5% |
| 5/4/2023 | $-0.14 | $-0.10 | +28.6% | $6.0M | $6.7M | +10.9% |
| 3/2/2023 | $-0.14 | $-0.14 | 0.0% | $6.2M | $6.2M | +1.1% |
| 11/9/2022 | $-0.12 | $-0.12 | 0.0% | $9.4M | $6.0M | -36.5% |
| 8/4/2022 | $-0.13 | $-0.10 | +23.1% | $6.8M | $14.2M | +110.4% |
| 5/5/2022 | $-0.13 | $-0.11 | +15.4% | $4.4M | $12.6M | +188.0% |
| 3/3/2022 | $-0.16 | $-0.15 | +6.3% | $2.9M | $3.2M | +11.2% |
| 11/4/2021 | $-0.24 | $-0.24 | 0.0% | $2.4M | $3.3M | +40.3% |
| 8/5/2021 | $-0.21 | $-0.23 | -9.5% | $2.1M | $2.3M | +9.9% |
| 5/5/2021 | $-0.22 | $-0.21 | +4.5% | $3.3M | $2.1M | -36.0% |
| 3/4/2021 | $-0.21 | $-0.23 | -9.5% | $2.0M | $2.4M | +17.5% |
| 11/5/2020 | $-0.20 | $-0.27 | -35.0% | $1.2M | $1.5M | +22.7% |
| 8/7/2020 | $-0.23 | $-0.25 | -8.7% | $1.5M | $1.5M | +4.2% |
| 5/11/2020 | $-0.32 | $-0.25 | +21.9% | $1.8M | $1.5M | -19.4% |
| 3/5/2020 | $-0.37 | $-0.36 | +2.7% | $1.3M | $1.6M | +27.8% |
| 11/6/2019 | $-0.11 | $-0.33 | -200.0% | $530,573.33 | $3.1M | +476.9% |
| 8/5/2019 | $-0.35 | $-0.46 | -31.4% | $525,239.13 | $653,000 | +24.3% |
| 5/6/2019 | $-0.31 | $-0.47 | -51.6% | $462,297.87 | $679,000 | +46.9% |
| 3/7/2019 | $-0.39 | $-0.37 | +5.1% | $1.8M | $1.7M | -7.5% |
| 11/7/2018 | $-0.39 | $-0.30 | +23.1% | $1.3M | $1.6M | +19.5% |
| 8/2/2018 | $-0.35 | $-0.44 | -25.7% | $49.8M | $1.2M | -97.5% |
| 5/3/2018 | $-0.38 | $-0.36 | +5.3% | $1.6M | $1.4M | -7.7% |
| 3/14/2018 | $-0.39 | $-0.90 | -130.8% | $1.1M | $2.5M | +130.8% |
| 11/2/2017 | $-0.38 | $-0.17 | +55.3% | $12.1M | $6.9M | -43.2% |
| 8/3/2017 | $-0.35 | $-0.28 | +20.0% | $1.3M | $1.0M | -21.4% |
| 5/4/2017 | $-0.30 | $-0.29 | +3.3% | $269,558.82 | $235,000 | -12.8% |
| 3/21/2017 | $-0.38 | $-0.38 | 0.0% | $48,750 | $195,000 | +300.0% |
| 11/3/2016 | $-0.53 | $-0.31 | +41.5% | $1.2M | $774,000 | -32.7% |
| 8/4/2016 | $-0.35 | $-0.35 | 0.0% | $48,789.47 | $309,000 | +533.3% |
| 5/4/2016 | $-0.37 | $-0.19 | +48.6% | $758,612.9 | $603,000 | -20.5% |
| 3/9/2016 | $-0.39 | $0.38 | +197.4% | $84.6M | $12.7M | -85.0% |
| 11/5/2015 | $-0.31 | $-0.31 | 0.0% | $9.8M | $4.1M | -58.6% |
| 8/5/2015 | $-0.25 | $-0.20 | +20.0% | $3.7M | $3.4M | -8.0% |
| 5/6/2015 | $-0.36 | $-0.36 | 0.0% | $4.2M | $4.7M | +11.1% |
| 3/12/2015 | $-0.28 | $-0.27 | +3.6% | $4.5M | $4.3M | -3.6% |
| 11/6/2014 | $-0.31 | $-0.39 | -25.8% | $3.5M | $4.4M | +25.8% |
| 8/13/2014 | $-0.26 | $-0.54 | -107.7% | $1.6M | $1.8M | +12.0% |
| 5/14/2014 | $0.23 | $-0.22 | -195.7% | $778,901.1 | $4.4M | +468.7% |
| 3/6/2014 | $0.05 | $-0.15 | -400.0% | — | $7.5M | — |
| 11/13/2013 | $-0.20 | $-0.40 | -100.0% | $3.3M | $3.0M | -9.1% |
| 8/12/2013 | — | $-0.20 | — | — | $2.8M | — |
| 5/14/2013 | — | $-0.18 | — | — | $2.2M | — |
| 8/14/2012 | $-0.16 | $-0.14 | +12.5% | $4.0M | $3.6M | -11.1% |
| 5/15/2012 | $-0.17 | $-0.25 | -47.1% | $3.1M | $3.6M | +14.5% |
| 3/27/2012 | — | $-0.15 | — | — | $3.9M | — |
| 11/8/2011 | $-0.30 | $-0.12 | +60.0% | $5.8M | $4.0M | -30.6% |
| 8/11/2011 | $-0.30 | $-0.33 | -10.0% | $4.1M | $4.6M | +11.1% |
| 5/10/2011 | $-0.36 | $-0.30 | +16.7% | $5.2M | $4.5M | -14.3% |
| 3/30/2011 | $-0.25 | $-0.20 | +20.0% | — | $6.7M | — |
| 11/15/2010 | $-0.20 | $-1.09 | -445.0% | $31.2M | $10.1M | -67.8% |
| 8/12/2010 | $-0.35 | $-0.40 | -14.3% | $1.9M | $2.4M | +28.4% |
| 6/30/2010 | — | $-0.39 | — | — | $2.2M | — |
| 3/17/2010 | $-0.30 | $-0.25 | +16.7% | — | $3.1M | — |
| 12/31/2009 | — | $-0.25 | — | — | $4.5M | — |
| 8/12/2009 | $-0.15 | $-0.20 | -33.3% | $3.3M | $3.3M | +0.0% |
| 5/13/2009 | $-0.25 | $-0.20 | +20.0% | $2.7M | $2.3M | -16.7% |
| 3/24/2009 | $-0.50 | $-0.35 | +30.0% | — | $4.0M | — |
| 12/31/2008 | — | $-0.10 | — | — | $1.5M | — |
| 6/30/2008 | — | $-0.70 | — | — | $2.5M | — |
| 3/31/2008 | — | $-0.09 | — | — | $1.9M | — |
| 11/14/2007 | $0.45 | $0.30 | -33.3% | $7.7M | $5.8M | -25.0% |
| 8/8/2007 | $-0.30 | $-1.05 | -250.0% | $3.8M | $2.8M | -25.9% |
| 6/30/2007 | — | $-0.98 | — | — | $2.8M | — |
Need ABUS data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.